newsfilter
← Latest News
GlobeNewswire·

Gain Therapeutics Reports Financial Results for Second Quarter 2026 and Provides Corporate Update

BETHESDA, Md., Aug. 11, 2026 (GLOBE NEWSWIRE) -- Gain Therapeutics, Inc. (NASDAQ:GANX) ("Gain", or the "Company"), a clinical-stage biotechnology company leading the discovery and development of the